52 Prevalence of CVD Risk Factors and their Treatment in Chronic, Stable Kidney Transplant Recipients in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial
Myra A. Carpenter, Andrew Bostom, John W. Kusek, Deborah Adey, Edward Cole, Andrew House, Matthew WeirVolume:
57
Year:
2011
Language:
english
Pages:
1
DOI:
10.1053/j.ajkd.2011.02.055
File:
PDF, 223 KB
english, 2011